BG CELL: autologous cell care at BGSS
BG CELL uses cells from your own blood and fat. They are prepared in a dedicated BG CELL Center with three specialised systems and returned to your body. Consultation, cell collection, processing and care are completed in one facility, usually on the same day, and cells never leave the center.
BG CELL Center
The dedicated cell center: facility, systems, team and the same-day process.
Learn more → (Korean) Care programBG CELL Care
Built around regeneration, immunity and healthy ageing as whole-body conditioning.
Learn more → (Korean) Adipose-derivedFat-derived stem cells
Mesenchymal stem cells (SVF) separated from a small amount of your own fat with PIOGEN-I.
Learn more → (Korean) Blood-derivedBlood-derived stem cells
Stem cells and regenerative signalling factors from a simple blood draw, activated on site.
Learn more → (Korean)Regenerative medicine at BGSS on video
From the clinic's Ministry of Health and Welfare designation to the launch of the BG CELL Center (Korean audio).
Korea's first ophthalmology clinic designated for advanced regenerative medicine : opening a new path for stem-cell research in macular degeneration and severe dry eye · April 2026
Regenerative treatments are provided under Korea's Advanced Regenerative Bio Act and government oversight. Suitability is assessed individually by our ophthalmologists, and results vary by person.
Regenerative Eye Medicine in Korea — Eligibility and How Assessment Works
BGSS is Korea's first ophthalmology clinic designated by the Ministry of Health and Welfare as an Advanced Regenerative Medicine Institution. Here is who may be eligible for assessment and how the process works.
- Designated under Korea's Advanced Regenerative Bio Act
- BG CELL Center, led by Dr. Jong-Ho Lee
- Specialist review of your records first
Can I receive regenerative eye treatment in Korea?
Possibly, depending on your diagnosis and Korean regulations. Regenerative eye care in Korea is provided only within the Advanced Regenerative Bio Act framework. BGSS is Korea's first ophthalmology clinic designated as an Advanced Regenerative Medicine Institution; its BG CELL Center researches corneal and retinal/macular regeneration. The first step is a specialist review of your medical records.
- Designation
- Advanced Regenerative Medicine Institution
- Framework
- Advanced Regenerative Bio Act
- Focus
- Cornea · retina/macula
- First step
- Specialist record review
Who may be considered for assessment?
General orientation only; eligibility is decided case by case by a specialist and depends on what regulations permit.
May be worth a specialist review
- Corneal surface or stromal conditions that have not responded to standard treatment
- Retinal or macular conditions where research approaches may be relevant
- Patients with complete records and recent imaging
- Patients seeking a second opinion on regenerative options
Not what regenerative care is for
- Correcting myopia, astigmatism or presbyopia → LASIK, SMILE Pro, ICL or lens surgery
- Replacing proven standard treatment that is working
- Conditions outside the permitted regulatory scope
- Expectations of a guaranteed cure
Your treatment plan and price within 24 hours
- 1 Send a photo of your glasses or prescription
- 2 Get a likely procedure and estimated cost
- 3 Reserve an exam slot for your trip
No obligation · English · 中文 · 日本語 · Tiếng Việt · Монгол · Bahasa Indonesia
How assessment works for international patients
Each step happens before any treatment decision.
Send records
Share your diagnosis, imaging (e.g. OCT, topography) and treatment history by WhatsApp; a coordinator replies within 24 hours.
Specialist review
A BGSS ophthalmologist reviews whether any regenerative approach is relevant and permitted for your condition.
In-person exam
If appropriate, a full examination in Seoul confirms the diagnosis and options.
Informed decision
Options, uncertainties, regulatory status and costs are explained before you decide; standard treatments are discussed alongside.
Which procedure fits your eyes?
Answer 3 quick questions to see the procedure most often suited to people like you, with the 2026 starting price. Then send it to a coordinator for a free personal review.
- FREE No obligation, no deposit to ask
- 24h Reply from our international team
- MD Final plan confirmed by an ophthalmologist after your exam
How old are you?
Written and reviewed by the surgeons who perform it
Every figure on this page is a published BGSS total or a public credential you can check.
- 160,000+ SMILE / SMILE Pro
- 66,000+ ICL lens implants
- 49,000+ presbyopia & cataract
- Many with M.D., Ph.D. research backgrounds
- Founder Dr. Jong-Ho Lee: 56,000+ ICL eyes
- Complex-case and toric ICL positioning
- STAAR Surgical EVO ICL APAC Experts Summit (2024)
- Korea SMILE Forum (2025)
- Korea EVO ICL Forum (2025)
- Among Korea's first to introduce LASIK & LASEK
- Ministry of Health & Welfare–designated regenerative medicine institution
- 2026 prices published openly
- Medical content reviewed by an ophthalmologist
Dr. Jong-Ho Lee, M.D., Ph.D.
Dr. Lee is a pioneer of first-generation LASIK, LASEK and ICL in Korea and is known internationally for complex-case ICL and custom lens positioning for astigmatism. He reviews the medical content on this website.
Editorial policy: clinical statements on this page are checked against the sources below and BGSS outcome data, and are reviewed at least once a year. Prices are the clinic's published 2026 rates.
Frequently asked questions
Is BGSS designated for regenerative medicine?
Yes. BGSS is Korea's first ophthalmology clinic designated by the Ministry of Health and Welfare as an Advanced Regenerative Medicine Institution.
What is the BG CELL Center?
BGSS's cell research centre, supporting research on corneal and retinal/macular regeneration, led by Dr. Jong-Ho Lee.
Can regenerative medicine replace LASIK or glasses?
No. Refractive errors are treated with proven procedures such as LASIK, SMILE Pro or ICL.
How much does it cost?
There is no standard price; it depends on diagnosis and regulatory approval, and is explained after specialist review.
Ready to see clearly? Start with a free consultation.
Send your prescription today and get a personal treatment plan and price estimate within 24 hours.
- Free consultation
- No obligation
- Reply within 24 hours
- Korea's first JCI-accredited eye clinic
Medical information on this page is for general education and does not replace a consultation with an ophthalmologist. Results vary by individual, and suitability is determined after a full pre-operative eye examination. Statistics: BGSS Seoul + Busan cumulative totals as of December 2025.
Advanced Regenerative Eye Treatment Korea | BGSS Eye Clinic Seoul
Ministry of Health & Welfare Designation
Advanced Regenerative Medicine Clinical Institution
Seoul BGSS Eye Clinic has been officially designated by the Korean Ministry of Health and Welfare as an Advanced Regenerative Medicine Clinical Institution, becoming the first ophthalmology clinic in Korea to receive this recognition.
This designation is granted only after passing strict government evaluations and verification processes. Under the Advanced Regenerative Bio Act, institutions must meet rigorous standards, including:
- State-of-the-art clinical facilities and equipment
- Highly trained medical specialists
- Standardized clinical protocols (SOP)
- Comprehensive safety and management systems
National-Level Recognition & Clinical Excellence
This certification represents official recognition of BGSS Eye Clinic’s:
- Advanced medical expertise
- Strong clinical research capabilities
- Commitment to patient safety and responsibility
Being selected as the first ophthalmology institution in Korea for advanced regenerative medicine highlights its leadership in the field.
Expanding into Next-Generation Eye Treatment
Through this designation, BGSS Eye Clinic is now authorized to conduct advanced research and treatment using:
- Stem cells
- Platelet-rich plasma (PRP)
- Cell-based regenerative therapies
These technologies enable the clinic to move beyond traditional treatments and explore innovative solutions for complex eye conditions.
Future of Vision Care: Regenerative Medicine
Advanced regenerative medicine focuses not only on tissue recovery but also on functional restoration, offering new possibilities for conditions such as:
- Retinal disorders
- Optic nerve damage
- Corneal diseases
This represents a shift toward future-oriented ophthalmology, where healing and regeneration go beyond conventional limits.
Commitment to Research & Innovation
BGSS Eye Clinic will expand its role from a surgical center to a research-driven medical institution, focusing on:
- Evidence-based clinical systems
- Advanced safety management
- Integrated research and treatment frameworks
The clinic plans to establish a specialized Advanced Ophthalmic Regenerative Medicine Center and expand into a digital-based eye health research hub.
Statement from Dr. Jong-Ho Lee (Founder)
Dr. Jong-Ho Lee, Director of BGSS Eye Clinic, stated:
“Based on this designation, we aim to establish a dedicated regenerative ophthalmology center focused on retinal and corneal diseases. Through stem cell research and advanced therapies, we will help patients with severe eye conditions achieve meaningful visual recovery and improved quality of life.”
29 Years of Clinical Data + AI Innovation
With over 29 years of clinical experience and 60,000+ accumulated surgical cases, BGSS Eye Clinic is integrating:
- Big data analytics
- Artificial Intelligence (AI) diagnostic systems
Through its proprietary system, BGSS AI, the clinic is advancing toward:
- More precise diagnosis
- Predictive treatment planning
- Next-generation personalized eye care
Leading the Future of Ophthalmology in Korea
BGSS Eye Clinic continues to evolve beyond current treatment standards, positioning itself as a
leading institution in future medical innovation and regenerative ophthalmology.
